Securities lawyers at Goldfarb LLP are investigating alleged violations of shareholder protection laws by officers and directors of Complete Genomics, Inc. (NASDAQ:GNOM) in connection with a buyout for $3.15 per share. Concerned GNOM investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or email@example.com about their rights and remedies. “This deal appears to undervalue the company because an analyst has set a target price for Complete Genomics, Inc. stock at $5.00 per share,” said Hamilton Lindley. “Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed and that the shareholders receive the highest price reasonably available for their GNOM stock.” Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. GNOM stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at firstname.lastname@example.org or 877-583-2855 with questions or concerns.
Complete Genomics (Nasdaq:GNOM) is trading at unusually high volume Tuesday with 5.6 million shares changing hands. It is currently at four times its average daily volume and trading down 23 cents (-7.7%).